Clinical Trial Update: Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating extracorporeal carbon dioxide removal for acute respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Intermountain Health Care, Inc. | Conditions: Acute Respiratory Distress Syndrome, Lung Diseases | Phase 3 | Status: COMPLETED